SS-31: Research Evidence, Safety Signals and Evidence Limitations
Also referenced as: Elamipretide, MTP-131, Bendavia
A literature-led overview of SS-31 — what has actually been measured in the published record, what remains unknown, and how research-grade material is characterised.
5 min read · Literature review · Updated 2026
Research-grade SS-31 vials — lot-matched certificate of analysis on request, from $39.99.
Shop SS-31What SS-31 is
A mitochondria-targeted tetrapeptide that associates with cardiolipin on the inner mitochondrial membrane. Unlike most materials in this library, it has been evaluated in randomised, placebo-controlled human trials, several of which did not meet their primary endpoints.
SS-31 is supplied as a research peptide in lyophilised form for laboratory research. The published record is dominated by published clinical and preclinical sources, which is the most important caveat when reading any summary of reported findings.
SS-31 research evidence
The areas below summarise what published work has actually measured. Each is an observation reported in the cited literature — not a claimed outcome, and not a statement of efficacy in humans.
Mitochondrial bioenergetics research
Published work has investigated cardiolipin binding and its reported association with electron-transport-chain efficiency in isolated mitochondria and preclinical models.
Clinical trial literature
Randomised, placebo-controlled trials have been published in primary mitochondrial myopathy and in Barth syndrome. Reported results were mixed, with primary endpoints not met in the larger controlled myopathy trial. No approved indication exists.
How it is described mechanistically
Mechanistic descriptions of SS-31 in the literature centre on the pathways below. Pathway attributions should be read as proposed rather than settled.
Cardiolipin association
Reported to bind cardiolipin on the inner mitochondrial membrane, an interaction discussed in the literature in relation to cristae structure and electron transport. Pathway noted in the literature: Cardiolipin / inner mitochondrial membrane.
SS-31 safety signals and evidence limitations
Controlled human trials have been published and reported safety data; this material is nonetheless not approved for human use and is supplied for laboratory research only.
No consistent adverse-event profile has been established for SS-31. The meaningful limitation is absence of data rather than a documented list of effects.
Open data gaps: long-term exposure data, regulatory approval status. Peptide Lounge does not publish dosing or administration guidance for any compound, and this material is not for human or veterinary use.
Analytical documentation and laboratory handling
Analytical values for SS-31 are lot-specific. Rather than publishing a universal figure, Peptide Lounge provides the lot-matched certificate of analysis for the batch you received on request, so the reported result corresponds to the material in hand.
Vials ship lyophilised and sealed. Store unopened vials according to the handling information supplied with the material and applicable literature. Solution preparation should use a solvent or buffer validated for the intended analytical method and material; consult applicable literature and lot-specific documentation. Peptide Lounge does not publish preparation, concentration or administration guidance.
How researchers source SS-31
SS-31 is stocked as single-compound vials in 10mg, 50mg, with volume pricing applied automatically to multi-vial orders. Free bacteriostatic water and research supplies are included on qualifying orders.
Related research vials
SS-31 — frequently asked questions
What does published research report about SS-31?
Published work describes mitochondrial bioenergetics research, clinical trial literature. Some of this record includes human data, but findings should still be read in the context of each study's design.
What safety signals have been reported for SS-31?
No established adverse-event profile exists. The substantive limitation is missing data: long-term exposure data, regulatory approval status.
Is SS-31 approved for human use?
No. SS-31 supplied by Peptide Lounge is a laboratory reagent for in-vitro and laboratory research only. It is not an approved drug and is not for human or veterinary use.
How is SS-31 supplied and handled?
SS-31 is supplied as a sealed lyophilised vial. Storage and solution preparation should follow the applicable literature and a solvent or buffer validated for the intended analytical method and material. Peptide Lounge does not publish preparation or administration guidance.
How do I verify the analytical results for a SS-31 vial?
Request the lot-matched certificate of analysis for the batch you received. Reported results are specific to that lot rather than a generic sample document.
Research areas
Mitochondrial bioenergetics research
Preclinical dataPublished work has investigated cardiolipin binding and its reported association with electron-transport-chain efficiency in isolated mitochondria and preclinical models.
Clinical trial literature
Human clinical dataRandomised, placebo-controlled trials have been published in primary mitochondrial myopathy and in Barth syndrome. Reported results were mixed, with primary endpoints not met in the larger controlled myopathy trial. No approved indication exists.
- • Limitation: Primary endpoints were not met in the principal controlled myopathy trial.
- • Limitation: Trial populations were small and disease-specific; findings do not generalise.
Mechanisms of action (as described in literature)
Cardiolipin association
Preclinical dataReported to bind cardiolipin on the inner mitochondrial membrane, an interaction discussed in the literature in relation to cristae structure and electron transport.
Cardiolipin / inner mitochondrial membrane
Published studies
No peer-reviewed study links are curated for this compound yet. Available information is limited to analytical and preclinical sources. Absence of linked studies should be read as an evidence gap.
Safety signals & data gaps
Reported signals only — safety is not established
Controlled human trials have been published and reported safety data; this material is nonetheless not approved for human use and is supplied for laboratory research only.
Known data gaps: Long-term exposure data, Regulatory approval status.
For Research Use Only
All products listed are supplied strictly as laboratory reagents for in-vitro research and analytical work conducted by qualified professionals. They are not drugs, foods, cosmetics or medical devices, and must not be administered to humans or animals. No product on this site is approved by the FDA for human use.
Research Use Only: Products are sold strictly for laboratory research and educational purposes only. Not for human consumption, veterinary use, food use, cosmetic use, or therapeutic application. Products are not intended to diagnose, treat, cure, or prevent any disease.

